Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04844840 · ClinicalTrials.gov registry record · Phase 2
A Study for Safety and Efficacy Evaluation of Various Doses of STP705 in Reducing Keloid Recurrence
A Phase 2 study, sponsored by Sirnaomics.
- Completed
- Registry status
- Phase 2
- Development phase
- 29
- Enrollment target
NCT04844840 is a Phase 2 study that has completed, run by Sirnaomics. The registered enrollment target is 29 participants.
The verdict
NCT04844840, a Phase 2 study, has completed, sponsored by Sirnaomics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 29 participants
- Enrollment target
Study Summary
Phase 2, randomized, double-blind, multiple arm, controlled study to evaluate safety \& efficacy of various doses of STP705 in reducing post Keloidectomy keloid recurrence.
Interventions
- OTHER Placebo
- DRUG STP705
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2021-04-29 |
| Est. Completion | 2023-05-17 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04844840
The ClinicalTrials.gov registry entry for NCT04844840 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sirnaomics, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04844840 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04844840 about?
NCT04844840 is a clinical study titled "A Study for Safety and Efficacy Evaluation of Various Doses of STP705 in Reducing Keloid Recurrence". Phase 2, randomized, double-blind, multiple arm, controlled study to evaluate safety \& efficacy of various doses of STP705 in reducing post Keloidectomy keloid recurrence.
What is the current status of trial NCT04844840?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 29 participants. The study started on 2021-04-29. Estimated completion is 2023-05-17.
What interventions are being tested in trial NCT04844840?
The interventions under investigation include: Placebo (OTHER), STP705 (DRUG).
Who is sponsoring clinical trial NCT04844840?
This trial is sponsored by Sirnaomics, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.